Gene therapy of solid tumors and hematopoietic neoplasms

作者: Carlos R. Bachier , Albert B. Deisseroth

DOI: 10.1007/978-1-4615-6349-5_1

关键词:

摘要: The ultimate goal in cancer treatment is to identify and correct at the molecular level derangements that cause various human malignancies. Important scientific discoveries about mechanisms through which develops are increasing likelihood introduction of foreign genetic material into mammalian cells may be used as a primary method therapy. Genetic modification malignant nonmalignant can performed on patient (in vivo) or removed from body (ex with subsequent reinfusion patient. Delivery systems gene therapy strategies have included transduction mediated by retrovirus, adenovirus, liposomes, direct injection DNA (table 1). manipulations aimed correcting disease processes already been introduced clinical trials. There now over 100 trials involving transfer antisense treatment, according records regulatory committees worldwide. These involve both marking based use designed for activation immune system, chemoprotection hematopoietic cells, chemosensitization tumor cells. major obstacles selectivity, frequencies, stability transduction, effectiveness due complexity alterations found tumors.

参考文章(58)
AB Deisseroth, Z Zu, D Claxton, EG Hanania, S Fu, D Ellerson, L Goldberg, M Thomas, K Janicek, WF Anderson, Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood. ,vol. 83, pp. 3068- 3076 ,(1994) , 10.1182/BLOOD.V83.10.3068.3068
N. Muzyczka, Use of adeno-associated virus as a general transduction vector for mammalian cells. Current Topics in Microbiology and Immunology. ,vol. 158, pp. 97- 129 ,(1992) , 10.1007/978-3-642-75608-5_5
Frank L. Graham, Ludvik Prevec, Manipulation of adenovirus vectors. Methods of Molecular Biology. ,vol. 7, pp. 109- 128 ,(1991) , 10.1385/0-89603-178-0:109
Lemoine Nr, Harris Jd, Gutierrez Aa, Sikora K, Hurst Hc, Gene therapy for cancer using tumour-specific prodrug activation. Gene Therapy. ,vol. 1, pp. 170- ,(1994)
A.Dusty Miller, Daniel G. Miller, J. Victor Garcia, Carmel M. Lynch, Use of retroviral vectors for gene transfer and expression. Methods in Enzymology. ,vol. 217, pp. 581- 599 ,(1993) , 10.1016/0076-6879(93)17090-R
X X Zhu, S Silverstein, C M Preston, R A Harris, R D Everett, Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. Journal of Virology. ,vol. 63, pp. 3513- 3515 ,(1989) , 10.1128/JVI.63.8.3513-3515.1989
Cynthia A. Richards, Brian E. Huber, Vincent C. Knick, Elizabeth A. Austin, Steven S. Good, Stephen Tibbels, In Vivo Antitumor Activity of 5-Fluorocytosine on Human Colorectal Carcinoma Cells Genetically Modified to Express Cytosine Deaminase Cancer Research. ,vol. 53, pp. 4619- 4626 ,(1993)